Jiangsu Cancer Hospital: Clinical Trials & Research Profile

Hospital / Clinical Site in Nanjing, China · Primary Specialty: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeClinical Trial Research Site
Institutional Sector & LocationHospital / Clinical Site (Nanjing, China)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies72 active (27 recruiting now)
Total Tracked Studies (2018 to 2026)118
Completed vs Early-Stopped Studies14 completed / 5 stopped (4.2% stop rate)
Median Closed Enrollment324 participants
Median Completed Study Duration1,380 calendar days
Physical Hospital Site Disclosure100.0% named hospital campus

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk